Dentons. (5/5/20). "Press Release: Dentons Advises Biotech Company Pluristem on European Investment Bank Financing". Düsseldorf & Frankfurt a. M..

	Region	EU (European Union)
	Organisation	Dentons Europe LLP, Frankfurt
	Group	Dentons (Group)
	Organisation 2	Pluristem Ltd.
	Group	Pluristem (Group)
	Product	legal services
	Product 2	PLX cells (PLacental eXpanded cells)
	Index term	Pluristem–Dentons: legal services, 202005 supply service Dentons is adivsor with regard to €50m EIB loan financing
	Index term 2	Pluristem–EU (govt): credit, 202004– EIB financing up to €50m in three milestone-dependent tranches
	Person	Schlieter, Axel (Dentons 202005 Partner at Düsseldorf Office)
	Person 2	Klüwer, Arne (Dentons 202005 Partner at Frankfurt Office)

Global law firm Dentons has advised the Israeli biotech company Pluristem on a €50 million loan provided by the European Investment Bank (EIB). The financing is part of a cooperation agreement between the EIB and the Israel Innovation Authority, which aims to strengthen Israeli-EU cooperation in innovative research in the field of biotech, pharmaceutical research and public health.

The venture loan will support research and development of Pluristem in the EU, including an innovative platform for regenerative cell therapy. The company will receive the financing in three tranches, subject to the achievement of pre-agreed clinical regulatory and scaling up milestones. The first tranche will consist of €20 million.

Pluristem is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. It is the first Israeli-European company to benefit from a venture loan from the European Fund for Strategic Investments (EFSI). The fund is a joint project of the EIB and the European Commission and provides financing to support innovative companies and future technologies in the EU. Dentons Banking and Finance partners Dr. Axel Schlieter (Düsseldorf) and Dr. Arne Klüwer (Frankfurt) advised Pluristem as venture borrower on the EIB financing. The mandate came about through Berlin-based partner Dirk-Reiner Voss.

About Dentons

Dentons is the world's largest law firm, delivering quality and value to clients around the globe. Dentons is a leader on the Acritas Global Elite Brand Index, a BTI Client Service 30 Award winner and recognized by prominent business and legal publications for its innovations in client service, including founding Nextlaw Enterprise, Dentons’ wholly owned subsidiary of innovation, advisory and technology operating units. Dentons' polycentric approach, commitment to inclusion and diversity and world-class talent challenge the status quo to advance client interests in the communities in which we live and work. www.dentons.com.

Key contacts

Dr. Axel Schlieter
Partner, Düsseldorf
D +49 211 74074 311
Email Me

Dr. Arne Klüwer
Partner, Frankfurt
D +49 69 4500 12 360
M +49 175 7290 352
Email Me

Record changed: 2024-08-24

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]